DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 180 filers reported holding DIPLOMAT PHARMACY INC in Q3 2018. The put-call ratio across all filers is 2.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $0 | – | 170 | +178.7% | 0.00% | – |
Q1 2019 | $0 | – | 61 | 0.0% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 61 | -87.3% | 0.00% | -100.0% |
Q3 2018 | $8,000 | -33.3% | 479 | -7.2% | 0.00% | -50.0% |
Q2 2018 | $12,000 | +50.0% | 516 | -12.5% | 0.00% | +33.3% |
Q1 2018 | $8,000 | 0.0% | 590 | +41.1% | 0.00% | 0.0% |
Q4 2017 | $8,000 | -27.3% | 418 | -25.8% | 0.00% | -40.0% |
Q3 2017 | $11,000 | +37.5% | 563 | 0.0% | 0.01% | +25.0% |
Q2 2017 | $8,000 | +300.0% | 563 | +288.3% | 0.00% | +300.0% |
Q1 2017 | $2,000 | +100.0% | 145 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $1,000 | -75.0% | 145 | 0.0% | 0.00% | -66.7% |
Q3 2016 | $4,000 | +33.3% | 145 | +52.6% | 0.00% | +50.0% |
Q2 2016 | $3,000 | +50.0% | 95 | -7.8% | 0.00% | +100.0% |
Q1 2016 | $2,000 | -77.8% | 103 | -64.2% | 0.00% | -83.3% |
Q4 2015 | $9,000 | – | 288 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
Investors Research Corp | 89,727 | $546,000 | 0.28% |
Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |